Go to the list of all blogs
Allana's Avatar
published in Blogs
Mar 12, 2019
TickeronGET DAILY SIGNALS
Hospital groups angry over proposed Medicaid and Medicare cuts

Hospital groups angry over proposed Medicaid and Medicare cuts

Hospital groups are objecting strongly to billions of dollars in proposed Medicare and Medicaid payment cuts in President Donald Trump's budget. Two major hospital trade groups did not mince words in blog posts Monday by their leaders.

Chip Kahn, president of the Federation of American Hospitals, is calling proposed Medicare cuts "arbitrary and blunt," adding, "the impact on care for seniors would be devastating." American Hospital Association President Rick Pollack says the budget raises "serious concerns about how hospitals and health systems can ensure they serve as the safety net" for patients. The budget includes a range of hospital cuts over 10 years, including reduced reimbursements for uncompensated care and lower rates for outpatient departments.

Related Ticker: IYH

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


IYH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IYH turned positive on October 12, 2026. Looking at past instances where IYH's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IYH as a result. In 74 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

IYH moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IYH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYH advanced for three days, in 250 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 212 of 254 cases where IYH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The 10-day RSI Indicator for IYH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 25 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 67 cases where IYH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

IYH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities in the healthcare sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Healthcare ETF (IYH) ETF is 80.82B. The market cap for tickers in the group ranges from 3.34B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is VKTX at 3.34B.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Healthcare ETF (IYH) ETF was 25%. For the same ETF, the average monthly price growth was 57%, and the average quarterly price growth was 407%. MDLN experienced the highest price growth at 20%, while IONS experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Healthcare ETF (IYH) ETF was -24%. For the same stocks of the ETF, the average monthly volume growth was -9% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 48
Price Growth Rating: 33
SMR Rating: 65
Profit Risk Rating: 71
Seasonality Score: 28 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
Hospital groups angry over proposed Medicaid and Medicare cuts